The Cigna Group: Compelling Exposure To Diversified Healthcare At A Discount Price
Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth by reducing Medicare exposure and improving Commercial business. Despite industry challenges, Cigna achieved 8%-9% YoY EPS growth in 2023-2024, demonstrating strong cost discipline and effective management. The sale of Cigna's Medicare unit and focus on lower-cost biosimilars and streamlined care accessibility are key strategic moves for future growth.
Cigna shuffles executive roles, names Ann Dennison as CFO
Cigna has made a series of upper management changes, which include making CFO Brian Evanko as the healthcare conglomerate's chief operating officer, and promoting his deputy Ann Dennison to the top finance role.
The Cigna Group (CI) Barclays 27th Annual Global Healthcare Conference (Transcript)
The Cigna Group (NYSE:CI ) Barclays 27th Annual Global Healthcare Conference Call March 12, 2025 2:00 PM ET Company Participants Brian Evanko - Chief Financial Officer of Cigna Group, President, Chief Executive Officer of Cigna Healthcare Conference Call Participants Andrew Mok - Barclays Andrew Mok Hi, good afternoon and welcome back to the Barclays Global Healthcare Conference. My name is Andrew Mok, I'm the facilities and managed care analyst here at Barclays.
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, resulted in lower earnings per share estimates. Many of the largest publicly traded US health insurers saw their medical costs grow in the fourth quarter and full year 2024, resulting in decreased revenues and lower-than-anticipated EPS, largely in line with analyst projections. Nearly across the board, the largest publicly traded US managed care insurers saw their medical care ratios rise from 2023 as changes to Medicare Advantage and Medicaid continued to impact profits.
Trump has good evidence money can be saved by cracking down on insurance industry: Former Cigna VP
Wendell Potter, former Cigna VP, joins 'Money Movers' to discuss how to explain what the DOJ's considering around UnitedHealth, the DOJ's history with solutions, and much more.
Cigna Is A Buy: Market Overreaction Creates A Big Opportunity
Cigna looks undervalued at under 10x earnings, with strong growth potential. Evernorth continues to expand, adding to the company's long-term value. Large stock buybacks are supporting earnings per share and investor returns.
Cigna Misses EPS: What It Means for the Health Insurance Industry
Leading health insurer Cigna Group Inc. NYSE: CI was praised for having the foresight to divest its Medicare Advantage (MA) business before rising acute care utilization rates would impact its medical care ratio (MCR) or medical benefits ratio (MBR), which the percentage of medical premiums paid out for medical reimbursement claims.
Health insurer Cigna says it will simplify claims process amid scrutiny
Cigna will roll out measures to simplify the process for physicians to submit claims and prior authorization requests, the U.S. health insurer said on Monday.
Why Cigna Stock Is Plummeting Today
Shares of Cigna (CI -7.49%) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m.
Cigna Q4 Earnings Miss Estimates on Decline in Medical Membership
CI's Q4 results reflect a decline in Individual and Family Plans customers. Management expects 2025 adjusted EPS at a minimum of $29.50, which indicates growth of at least 7.9% from the 2024 figure.
The Cigna Group (CI) Q4 2024 Earnings Call Transcript
The Cigna Group (NYSE:CI ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants David Cordani - Cigna Group's Chairman, Chief Executive Officer Brian Evanko - Chief Financial Officer of Cigna Group, President, Chief Executive Officer of Cigna Healthcare Eric Palmer - President, Chief Executive Officer of Evernorth Health Services Ralph Giacobbe - Senior Vice President of Investor Relations Conference Call Participants Justin Lake - Wolf Research Stephen Baxter - Wells Fargo Charles Rhyee - TD Cowen Lisa Gill - JP Morgan AJ Rice - UBS Scott Fidel - Stephens Erin Wright - Morgan Stanley Andrew Mok - Barclays Josh Raskin - Nephron Research Adam Ron - Bank of America Ann Hynes - Mizuho Security Sarah James - Cantor Fitzgerald Ben Hendrix - RBC Capital Markets George Hill - Deutsche Bank Operator Ladies and gentlemen, thank you for standing by for the Cigna Group's Fourth Quarter 2024 Results Review. At this time all callers are in a listen-only mode.
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
